BlockBeats News, November 20th, JPMorgan Chase's trading department stated that the longest continuous decline in the US stock market since August has created buying opportunities for dip buyers. Due to investor concerns about the sustainability of the artificial intelligence concept rally and the Federal Reserve's monetary policy path, the S&P 500 index has fallen for four consecutive days, closing down 3.4% as of Tuesday's close.
JPMorgan Chase's Global Market Insights Director, Andrew Tyler, stated that this pullback represents a one-time "technical shakeout" in the stock market, and the adjustment period may have ended.
"Given that there have been no fundamental changes and our investment thesis does not depend on Fed easing policy, it is now possible to buy on the dip," Tyler wrote in a report to clients on Wednesday. (FX678)
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.









Key Takeaways Stablecoins are expected to become essential financial infrastructure by 2026, facilitating real-time settlements and expanding access…





Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.
